Clinical Trials

Showing trials with last updates posted in 2022.

NCT03584009 | TERMINATED | PHASE2
103 participants

A Phase II Study Comparing The Efficacy Of Venetoclax + Fulvestrant Vs. Fulvestrant In Women With Estrogen Receptor-Positive, Her2-Negative Locally Advanced Or Metastatic Breast Cancer Who Experienced Disease Recurrence Or Progression During Or After CDK4/6 Inhibitor Therapy

Study Type:
INTERVENTIONAL
Last Updated:
2022-06-28
Start Date:
2018-09-06
Completion:
2020-08-05
Conditions
  • Estrogen Receptor-positive (ER+)/Human Epidermal Growth Factor Receptor (HER2)-Negative Locally Advanced or Metastatic Breast Cancer
Interventions
  • DRUG
Previous
Sorted by latest updates
Next
Showing 40 trials per page